The proposed research program applies Solidus technology in microarraying, biocatalysis, and screening and the Linhardt group's expertise in heparin/heparan sulfate to the field of glycomics. Glycomics, the comprehensive study of glycan structure-function relationship, is a sub-discipline of metabolomics and the next step beyond genomics and proteomics. Heparin glycosaminoglycans (heparin and heparan sulfate) are among the most structural complex biopolymers. These glycans carry and store significant biological information crucial in virtually all pathological and pathophysiological processes involving cell-cell interaction and communication.
The specific aims and milestones of this Phase I STTR proposal are to: 1. prepare a heparin glycan microarray; 2. probe this microarray with the highly specific heparin-binding protein, antithrombin III; 3. prepare an enzyme-modified heparosan microarray; 4. probe this microarray with a collection of heparin-binding proteins to examine binding specificity; and 5. prepare a structurally defined glycan microarray based on the glycosyltransferase extension, and enzymatic modification of heparosan oligosaccharide acceptors for probing with heparin-binding proteins. Phase I will focus on developing the core technology required for developing a HepGly chip as a glycomics platform for screening interactions with heparin-binding proteins. Potential applications for a HepGly microarray include the development of the next generation of heparin-based drugs, the evaluation small molecule drugs that antagonize with heparin/heparan sulfate interaction with heparin-binding proteins and the rapid screening of biological samples in diagnostic applications. A phase II proposal will be prepared to develop these commercial applications. ? ? ?

National Institute of Health (NIH)
National Center for Research Resources (NCRR)
Small Business Technology Transfer (STTR) Grants - Phase I (R41)
Project #
Application #
Study Section
Special Emphasis Panel (ZRG1-BCMB-L (11))
Program Officer
Sheeley, Douglas
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Solidus Biosciences, Inc.
San Francisco
United States
Zip Code
Fu, Li; Zhang, Fuming; Li, Guoyun et al. (2014) Structure and activity of a new low-molecular-weight heparin produced by enzymatic ultrafiltration. J Pharm Sci 103:1375-83
Sterner, Eric; Li, Lingyun; Paul, Priscilla et al. (2014) Assays for determining heparan sulfate and heparin O-sulfotransferase activity and specificity. Anal Bioanal Chem 406:525-36
Sterner, Eric; Meli, Luciana; Kwon, Seok-Joon et al. (2013) FGF-FGFR signaling mediated through glycosaminoglycans in microtiter plate and cell-based microarray platforms. Biochemistry 52:9009-19
Puvirajesinghe, Tania M; Turnbull, Jeremy E (2012) Glycomics approaches for the bioassay and structural analysis of heparin/heparan sulphates. Metabolites 2:1060-89
Masuko, Sayaka; Higashi, Kyohei; Wang, Zhenyu et al. (2011) Ozonolysis of the double bond of the unsaturated uronate residue in low-molecular-weight heparin and K5 heparosan. Carbohydr Res 346:1962-6
Laremore, Tatiana N; Leach 3rd, Franklin E; Amster, I Jonathan et al. (2011) Electrospray ionization Fourier transform mass spectrometric analysis of intact bikunin glycosaminoglycan from normal human plasma. Int J Mass Spectrom 305:109-115
Ly, Mellisa; Laremore, Tatiana N; Linhardt, Robert J (2010) Proteoglycomics: recent progress and future challenges. OMICS 14:389-99
Liu, Haiying; Zhang, Zhenqing; Linhardt, Robert J (2009) Lessons learned from the contamination of heparin. Nat Prod Rep 26:313-21
Zhang, Zhenqing; Park, Youmie; Kemp, Melissa M et al. (2009) Liquid chromatography-mass spectrometry to study chondroitin lyase action pattern. Anal Biochem 385:57-64
Martin, Jeffrey G; Gupta, Megha; Xu, Yongmei et al. (2009) Toward an artificial Golgi: redesigning the biological activities of heparan sulfate on a digital microfluidic chip. J Am Chem Soc 131:11041-8

Showing the most recent 10 out of 28 publications